Sector pending / Biological Products, Except Diagnostic SubstancesUpdated 2026-05-10 22:07 UTC

XKON/229500 stock hub

XKON/229500 has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

XKON/229500is not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

113.9B

Korea New Exchange

Market data

Live price

Current market quote for this ticker.

Current price

XKON/229500

In the news

Latest news · XKON/229500

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 n/aP50 n/aP75 n/a

Trailing P/E73.9

P25 n/aP50 n/aP75 n/a

ROE10.8

P25 n/aP50 n/aP75 n/a

ROIC-2

P25 n/aP50 n/aP75 n/a

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All XKON/229500 market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

139

Groups with data

Currency

KRW

Showing 139 of 139 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	South Korea
Country code	KR
Exchange	Korea New Exchange
Financial currency	KRW
First seen	2026-05-10
Industry	Biological Products, Except Diagnostic Substances
Last refreshed	2026-05-10
Market cap	KRW 113.9B
Price	KRW 8,870
Price currency	KRW
Sic	2836
Symbol	xkon/229500
Website	https://www.novmeta.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	0.36%
FCF yield	-0.23%
P/B ratio	21.41x
P/E ratio	73.92x
P/S ratio	87.92x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	-9.52%
EBITDA Margin	-5.8%
Gross margin	47.26%
Gross Profit	KRW 612.3M
Net Income	KRW 408M
Pretax Margin	31.5%
Profit Margin	31.5%
ROA	-1.96
ROCE	-2.28
ROE	10.84
ROIC	-2.05

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	8.31%
Cagr3y	-15.97%
Cagr5y	-18.19%
Revenue Growth	21.36x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	KRW 0.33
Assets	KRW 5.5B
Cash	KRW 3.5B
Current Assets	KRW 4B
Current Liabilities	KRW 123.9M
Equity	KRW 5.3B
Liabilities	KRW 205.6M
Long Term Assets	KRW 1.5B
Long Term Liabilities	KRW 81.7M
Net Cash	KRW 3.5B
Net Cash By Market Cap	KRW 3.07
Net Debt Equity	KRW -0.66
Tangible Book Value	KRW 5.3B
Tangible Book Value Per Share	KRW 1,555
WACC	5.23

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	32.26
Inventory Turnover	3.01
Net Working Capital	KRW 376.6M
Quick ratio	28.62
Working Capital	KRW 3.9B

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	8.3%
200-day SMA	12,706.9
3Y total return	-40.67%
50-day SMA	9,577.8
50-day SMA vs 200-day SMA	50under200
5Y total return	-63.35%
All Time High	96,100
All Time High Change	-90.77%
All Time High Date	2018-04-18
All Time Low	4,505
All Time Low Change	96.89%
All Time Low Date	2024-09-06
ATR	896.5
Beta	0.18
Beta1y	0.48
Beta2y	0.62
Ch YTD	-34.3
High	9,350
High52	17,890
High52 Date	2025-07-29
High52ch	-50.42%
Low	8,500
Low52	6,800
Low52 Date	2026-03-26
Low52ch	30.44%
Ma50ch	-7.39%
Price vs 200-day SMA	-30.2%
RSI	40.66
RSI Monthly	43.65
RSI Weekly	41.08
Sharpe ratio	0.46x
Sortino ratio	0.83
Tr YTD	-34.3
Tr1m	-36%
Tr1w	0.11%
Tr3m	-18.02%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	KRW -123.4M
Operating margin	-9.52

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	9,242,331%
Shares Insiders	25.58%
Shares Out	12,841,554

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	KRW -263.8M
Average Volume	7,911.65x
Bv Per Share	1,564.9
CAPEX	KRW -84.4M
Ch1m	-36
Ch1w	0.11
Ch1y	8.3
Ch3m	-18.02
Ch3y	-40.67
Ch5y	-63.35
Ch6m	-33.31
Change	-2.95%
Change From Open	-1.55
Close	9,140
Days Gap	-1.42
Depreciation Amortization	48,178,000
Dollar Volume	56,883,310
EBIT	KRW -123.4M
EBITDA	KRW -75.2M
EPS	KRW 120
F Score	1
FCF	KRW -263.8M
FCF Per Share	KRW -20.54
Financing CF	2,702,632,000
Fiscal Year End	December
Founded	2,010
Graham Number	2055.53037
Graham Upside	-76.83
Investing CF	-1,435,932,000
Is Primary Listing	1
Ma150	12,096.2
Ma150ch	-26.67%
Ma20	10,014.5
Ma20ch	-11.43%
Net CF	1,087,341,000
Open	9,010
Position In Range	43.53
Ppne	70,393,000
Price Date	2026-05-08
Ptbv Ratio	21.55
Relative Volume	0.81x
Revenue	1,295,493,000x
Tr6m	-33.31%
Volume	6,413
Z Score	0.95

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does XKON/229500 pay a dividend?

Capital-return profile for this ticker.

Performance

XKON/229500 stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns XKON/229500?

Insider, institutional, and short-interest positioning.

Institutional ownership

n/a

Share of float held by funds and institutions

Insider ownership

+25.6%

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

n/a

Negative means the company is buying back shares.

Technical

XKON/229500 momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

40.7

Neutral momentum band

Price vs 200-day MA

-30.2%

50/200-day relationship not available

Beta (5Y)

0.18

Less volatile than the market

Sharpe ratio

0.46

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About XKON/229500

Hub-level FAQ points readers to the deeper analysis pages.

What is the current xkon/229500 stock rating?

xkon/229500 is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full xkon/229500 analysis?

The full report lives at /stocks/xkon/229500/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for xkon/229500?

The latest report frames xkon/229500 around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the xkon/229500 page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.